✦ LIBER ✦

Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: An open-label comparative study of efficacy and safety

✍ Scribed by Valentina Zipoli; Emilio Portaccio; Bahia Hakiki; Gianfranco Siracusa; Sandro Sorbi; Maria Pia Amato

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open label pilot study evaluating the

✍ Maria Dubinsky; Philip Hassard; Lori Kam; Maria Abreu; Ernest Seidman; Stephan T 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 36 KB

3046 POSTER A randomized, open-label pha

✍ T.E. Ciuleanu; W. Scheithauer; G. Kurteva; J. Ocvirk; I. Koza; D. Papamichael; M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

An open-label, single-arm Phase II study

✍ Peter G. Rose; Bradley J. Monk; Diane Provencher; Jean Hartney; Philippe Legenne 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 192 KB